Search results
Author(s):
Deepak L Bhatt
,
Harriette Van Spall
Added:
2 years ago
Dr Harriette Van Spall (McMaster University, Hamilton, CA) and Dr Deepak L Bhatt (Brigham and Women's Hospital, Boston, MA, US) discussed the latest data on the benefits of SGLT1/2 inhibition across the full spectrum of ejection fraction, including HFpEF.
Recorded remotely from Boston and Hamilton, 2021.
Editor: Mirjam Boros
View more
Author(s):
Harald Thune Jorstad
Added:
2 years ago
In this video, Dr Harald Thune Jorstad (Academic Medical Center, Amsterdam, NL) discusses the findings of RESPONSE-2, a randomised trial aiming to investigate the long-term outcomes of community-based lifestyle interventions in coronary artery disease (CAD) patients.
The study showed that at 3 years follow-up, the benefits of 1 year of nurse-coordinated referral to community-based lifestyle…
View more
Author(s):
Antonio J Vallejo-Vaz
Added:
3 years ago
Heart Failure – A Major Global Health Problem
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality in developed countries and its burden is progressively increasing.1–4 Coronary artery disease (CAD) and other conditions, such as hypertensive heart disease or diabetes mellitus, are rated among the foremost reasons for morbi-mortality worldwide.1–4 In this context,…
View more
Author(s):
Mahmoud Abdelnabi
,
Nouran Eshak
,
Yehia Saleh
,
et al
Added:
3 years ago
Pathophysiology of COVID-19-related Cardiac Injury
Acute myocarditis is a potentially life-threatening disease, which is most commonly caused by a viral infection. Among the viruses, the most cited are enteroviruses (especially coxsackievirus), adenovirus and parvovirus B19 and, rarely, coronavirus.
Recently, coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory…
View more
Author(s):
Kensuke Nishimiya
,
Jun Takahashi
,
Kazuma Oyama
,
et al
Added:
10 months ago
Michael S Firstenberg
Job title: Director of Research and Special Projects
Author
Author(s):
Javed Butler
,
Stefan Anker
Added:
5 years ago
Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker
Filmed on-site at ESC 2018 by Radcliffe Cardiology.
View more
Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia
Author(s):
Ricardo A Perez de la Hoz
,
Sandra Patricia Swieszkowski
,
Federico Matias Cintora
,
et al
Added:
3 years ago
Article
Author(s):
Kazuma Ohyama
,
Yasuharu Matsumoto
,
Hiroaki Shimokawa
Added:
3 years ago
Coronary Artery Spasm and Adventitial Inflammation
Coronary artery spasm plays an important role in the pathogenesis of a wide range of ischaemic heart disease, not only in variant angina, but also in other forms of angina pectoris and myocardial infarction.1,2 Recent studies have demonstrated that coronary spasm is also as frequently noted in European people as in Asian people.3
We have…
View more
Author(s):
Juan Tamargo
Added:
3 years ago
In the article by Juan Tamargo entitled Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments (European Cardiology Review 2019;14(1):23–32. https://doi.org/10.15420/ecr.2018.34.2), the following correction should be made:
Figure 1 should indicate an increase (↑) in haemoglobin and haematocrit, not a decrease (↓). The…
View more